Home › Funds › BRAUN STACEY ASSOCIATES INC › DGX
BRAUN STACEY ASSOCIATES INC position in DGX
QUEST DIAGNOSTICS INC · Health Care
BRAUN STACEY ASSOCIATES INC reported holding 145,838 shares of DGX (QUEST DIAGNOSTICS INC) in its Q3 2026 13F filing — a position valued at US$34.0M, representing 0.98% of its reported portfolio and ranking #30 among its reported holdings. BRAUN STACEY ASSOCIATES INC has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR
How BRAUN STACEY ASSOCIATES INC's DGX position evolved
BRAUN STACEY ASSOCIATES INC first disclosed a stake in DGX in Q2 2025 at 135,952 shares (US$24.4M). The position peaked in Q3 2026 at 145,838 shares, worth US$34.0M. Across 6 filings, BRAUN STACEY ASSOCIATES INC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 145,838 shares valued at US$34.0M — a reduction of -8,558 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 135.95K | $24.42M | New |
| Q3 2025 | 154.37K | $29.42M | Add |
| Q4 2025 | 153.85K | $26.70M | Hold |
| Q1 2026 | 156.83K | $30.74M | Add |
| Q2 2026 | 154.40K | $32.72M | Reduce |
| Q3 2026 | 145.84K | $33.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DGX and 13F data
DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DGX
- Boston Partners 4.74M sh · $1.00B · Q2 2026
- EdgePoint Investment Group Inc. 2.25M sh · $476.37M · Q2 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 1.89M sh · $400.21M · Q2 2026
- DAVIS SELECTED ADVISERS 1.56M sh · $329.78M · Q2 2026
- M&G Plc 795.65K sh · $168.68M · Q2 2026
More on BRAUN STACEY ASSOCIATES INC
FAQ
How long has BRAUN STACEY ASSOCIATES INC held DGX?
BRAUN STACEY ASSOCIATES INC has disclosed DGX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is BRAUN STACEY ASSOCIATES INC's current position in DGX?
As of Q3 2026, BRAUN STACEY ASSOCIATES INC holds 145.84K shares of DGX (QUEST DIAGNOSTICS INC), valued at $33.99M, representing 0.98% of its reported portfolio and ranking #30.
Has BRAUN STACEY ASSOCIATES INC been buying or selling DGX?
In the latest 13F filing (Q3 2026), BRAUN STACEY ASSOCIATES INC reduced its position in DGX. The position peaked in Q3 2026 at 145.84K shares.
Which other funds hold DGX?
Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.